Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$6.04
NASDAQLPCN
Open
$5.74
Change
$0.29 (5.04%)
Day's Range
$5.74 - $6.30
52-Week Range
$2.31 - $7.15
Volume
49.1K
Market Cap
$32.3M